This is a working overview of triple agonist, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-10 and is reviewed periodically as new material appears.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
Acting as a triple agonist, the molecule binds the GLP-1, GIP, and glucagon receptors. GLP-1 activity slows gastric emptying and dampens appetite, while GIP signaling contributes to insulin sensitivity and fat metabolism. Glucagon receptor engagement raises energy expenditure and encourages fat breakdown, although it can also elevate blood glucose. Combining three pathways is intended to yield larger weight reduction than single or dual agonists, and researchers continue to examine how the balance among them shapes tolerability.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Not a small molecule |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist activity |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in water | Also in aqueous buffers |
| Storage | −20 °C or below | Protect from light and moisture |
Characterising a peptide of this size relies on a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact molecule from related impurities, while electrospray mass spectrometry confirms molecular mass and detects truncation or oxidation products. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates modified residues. Because the molecule carries a lipid chain, assays must also distinguish the correctly conjugated product from incompletely acylated species.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
Mechanistic proposals link each receptor to a different physiological role. Activation of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors is associated with reduced appetite, slower gastric emptying, and glucose-dependent insulin release. Glucagon receptor signaling, by contrast, is associated with increased energy expenditure and altered lipid handling, though it can also raise blood glucose. The design intent is to balance these contributions so that weight reduction is enhanced without unacceptable glycemic trade-offs. How well that balance holds across individuals is not fully resolved.
=== Production of ethylene glycol === Ethylene glycol is industrially produced by non-catalytic hydration of ethylene oxide at a temperature of 200 °C (392 °F) and a pressure of 1.5–2 MPa (220–290 psi):
Wendy Greengross (29 April 1925 – 10 October 2012); author of books on pastoral care and counselling, journalist, general practitioner and broadcaster. The Independent called her "a pioneering counsellor and one of the leading figures in fighting for equal rights for the disabled and the elderly"; went into broadcasting, joining BBC Radio 4 counselling programme If You Think You've Got Problems; also had her own television show on BBC1, Let's Talk it Over; father was mayor of Holborn, and brother Sir Alan Greengross (born 1929) was Conservative member of Greater London Council. Tony Greenstein (born December 1953) is a left-wing anti-fascist, anti-Zionist writer activist, whose father came from a rabbinical family. Author of The Fight Against Fascism in Brighton & the South Coast, Zionism: Antisemitism's twin in Jewish garb and Zionism During the Holocaust: Weaponising Memory in the Service of State and Nation. John Hajnal (born Hajnal-Kónyi; 26 November 1924 – 30 November 2008), was Hungarian-British academic in fields of mathematics and economics (statistics); author of numerous monographs and academic papers and a book on the inefficacy of the British education system “The student trap: A critique of university and sixth-form curricula”; best known for identifying, in landmark 1965 paper, the historical pattern of marriage of northwest Europe in which people married late and many adults remained single.
In contrast to ALP, levels of ALT, AST, GGT, and lactate dehydrogenase are only slightly changed or largely unchanged during pregnancy. Bilirubin levels are significantly decreased in pregnancy. In pregnancy conditions such as hyperemesis gravdirum, ALP levels can reach 215 IU/L, meanwhile, in pre-eclampsia, ALP can reach 14 IU/L, and in HELLP syndrome ALP levels can reach 15 IU/L.
Sources: en.wikipedia.org
Alternative Splicing: In this mechanism, alternative splicing of the RAGE gene produces a variant that lacks the membrane-anchoring and cytoplasmic segments, creating a soluble form of the receptor Proteolytic Cleavage: Alternatively, sRAGE can be produced by proteolytic cleavage of the membrane-bound receptor. This involves enzymes, such as matrix metalloproteinases (MMPs) and ADAM10, cleaving the extracellular portion of mRAGE, which is then released into the circulation.
Blowing over a curved piece of paper does not demonstrate Bernoulli's principle. Although a common classroom experiment is often explained this way, Bernoulli's principle applies only within a flow field, and the air above and below the paper are in different flow fields. The paper rises because the air follows the curve of the paper and a curved streamline will develop pressure differences perpendicular to the airflow. The Coriolis effect does not cause water to consistently drain from basins in a clockwise/counter-clockwise direction depending on the hemisphere. The common myth often refers to the draining action of flush toilets and bathtubs. In fact, rotation is determined by whatever minor rotation is initially present at the time the water starts to drain, as the magnitude of the Coriolis acceleration is negligibly small compared to the inertial acceleration of flow within a typical basin. General relativity does not imply that mass increases as an object approaches the speed of light; it is an object's momentum, a quantity dependent upon both mass and velocity, that increases asymptotically as it approaches the speed of light. The mass-energy equivalence equation is thus more accurately expressed as E=γmc², where γ is a variable dependent upon velocity. For an object at rest, γ=1 resulting in the familiar equation E=mc². Neither gyroscopic forces nor geometric trail are required for a rider to balance a bicycle or for it to demonstrate self-stability.
== Etymology == The term is derived from integumentum, which is Latin for "a covering". In a transferred, or figurative sense, it could mean a cloak or a disguise. In English, "integument" is a fairly modern word, its origin having been traced back to the early seventeenth century; and refers to a material or layer with which anything is enclosed, clothed, or covered in the sense of "clad" or "coated", as with a skin or husk.
Sources: en.wikipedia.org
Arsenic exposure plays a key role in the pathogenesis of vascular endothelial dysfunction as it inactivates endothelial nitric oxide synthase, leading to a reduction in the generation and bioavailability of nitric oxide. In addition, chronic arsenic exposure induces high oxidative stress, which may affect the structure and function of the cardiovascular system. Further, the arsenic exposure has been noted to induce atherosclerosis by increasing the platelet aggregation and reducing fibrinolysis. Moreover, arsenic exposure may cause arrhythmia by increasing the QT interval and accelerating the cellular calcium overload. The chronic exposure to arsenic upregulates the expression of tumor necrosis factor-α, interleukin-1, vascular cell adhesion molecule and vascular endothelial growth factor to induce cardiovascular pathogenesis. Arsenic has also been shown to induce cardiac hypertrophy by activating certain transcription factors involved in pathologically remodeling the heart. Tissue culture studies have shown that arsenic compounds block both IKr and Iks channels and, at the same time, activate IK-ATP channels. Arsenic compounds also disrupt ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress.
Homotropic allosteric enzymes: substrate and effector play a part in the modulation of the enzyme, which affects the enzyme catalytic activity. Heterotropic allosteric enzymes: only the effector performs the role of modulation.
=== Branding === In 1996, while renovating the first Raising Cane’s location near LSU, Graves uncovered an old mural from a former bakery, "Wolf's Bakery", that inspired the restaurant's logo with its red-brick tones, flowing white script, and a yellow tagline declaring "bread at its best". The name "Raising Cane's" pays tribute to his yellow Labrador, Cane. Locations feature custom murals. These brand elements can be seen in official merchandise released by Raising Cane's. In addition, Raising Cane's sells limited-edition merchandise, like the Graduation Plush Puppy released in 2025. They held a fashion show in 2025 at New York Fashion Week, designed by Joe Ando-Hirsh.
Sources: en.wikipedia.org
Retatrutide is an investigational synthetic peptide that activates three metabolic receptors: GLP-1, GIP, and glucagon. It is being studied for obesity and type 2 diabetes. It has not been approved for clinical use.
Earlier incretin therapies engage one or two receptors. Retatrutide adds glucagon receptor activity, which may raise energy expenditure. Whether this produces larger clinical benefits is still being tested.
It has completed phase 2 trials and moved into later-stage evaluation. No regulator has granted approval. Access outside research settings is not authorized.
It is a synthetic peptide classified as a triple receptor agonist. It engages the GLP-1, GIP, and glucagon receptors at once. It is investigated for metabolic and weight-related conditions rather than approved for general use.